Gregory Makris: Factor XI Makes the Leap from OCEANIC Stroke to the ESO 2025 Update
Gregory Makris, Senior Director in Global Medical Affairs, Cardiovascular and Thrombosis at Bayer, shared on LinkedIn:
”Stroke medicine is evolving rapidly, with emerging evidence continuously informing clinical practice!
A few days after the release of the OCEANIC Stroke trial, it is great to see Factor XI making it to the European Stroke Organisation annual stroke evidence update for 2025!
There is no time to lose when it comes to preventing secondary strokes!”
Title: ESO annual stroke evidence update 2025
Authors: Diana Aguiar de Sousa, Aristeidis H Katsanos, Linxin Li, Nicolas Martinez-Majander, John McCabe, Lina Palaiodimou, Anna Ramos Pachon, Michele Romoli, Peter D Schellinger, Annaelle Zietz, Sven Poli, Melinda Roaldsen, Ashkan Shoamanesh, Marek Sýkora, Georgios Tsivgoulis
Read the Full Article on European Stroke Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery
-
Jul 7, 2026, 20:58Chokri Ben Lamine: The Two-Hit Model of TRALI
-
Jul 7, 2026, 20:57New Issue of Blood Out Now – Blood Journals Portfolio
-
Jul 7, 2026, 20:56Priyadarshini Ramakrishnan: Schistocytes – The Most “Misleading Heroes” in a Peripheral Smear